Ahasan, M.H. et al. 2022. Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. University Heart Journal. 18, 1 (Jan. 2022), 10–13. DOI:https://doi.org/10.3329/uhj.v18i1.57874.